<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="211903">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00328016</url>
  </required_header>
  <id_info>
    <org_study_id>AG0067</org_study_id>
    <nct_id>NCT00328016</nct_id>
  </id_info>
  <brief_title>Breathe: Slow Paced Breathing to Lower Blood Pressure</brief_title>
  <official_title>Respiratory Adaptations to Behavioral Interventions in Elevated Blood Pressure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the nature of the physiological reasons for the
      decreases in resting blood pressure that can result from systematic practice of
      computer-guided breathing exercises or meditative relaxation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this randomized clinical trial, persons with moderately elevated blood pressure will be
      trained in either computer-guided breathing exercises or meditative relaxation. The
      computer-guided breathing exercise involves listening to tones of ascending and descending
      pitch to which breathing is entrained to low frequencies over a 15 minute interval. The
      meditative relaxation involves passive attention to natural breathing for the same duration.
      Participants will perform these breathing exercises daily at home for four weeks. Before and
      after the intervention, respiratory, cardiovascular, and urinary endogenous digitalis-like
      factors will be systematically recorded to determine the extent to which chronic
      neuroendocrine changes underlie the reductions in blood pressure.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2006</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in tidal volume and minute ventilation during guided breathing</measure>
    <time_frame>before (10 min), during (15 min) and following (10 min) initial performance of the breathing task, and 28 days later</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in blood pressure, end tidal CO2 and heart rate variability</measure>
    <time_frame>during guided breathing and 28 days later</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in 24 hour blood pressure and urinary marinobufagenin excretion</measure>
    <time_frame>after 28 days of guided breathing</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>High Blood Pressure</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Guided Breathing</intervention_name>
    <description>The participant will engage in daily 15 min sessions of meditative relaxation that involves quiet attention to breathing pattern with no attempt to manipulate breathing pattern</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Resperate</intervention_name>
    <description>The participant will be trained to perform a guided breathing task that involves a chest expansion sensor, battery-powered microcomputer, and earphones</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Over 21 years

          -  Systolic blood pressure 130-160 or diastolic blood pressure 85-100

        Exclusion Criteria:

          -  More than one antihypertensive medication

          -  Beta blockers, angiotensin converting enzyme inhibitors or angiotensin receptor
             blockers

          -  History of coronary artery disease, heart failure, stroke, angina or coronary
             revascularization

          -  Kidney disease, defined as plasma creatinine &gt; 1.5mg/dL

          -  Diabetes, defined by insulin or oral hypoglycemic medication or blood sugar &gt;
             126mg/dL

          -  Pulmonary disease, defined as chronic obstructive pulmonary disease, bronchitis,
             asthma, or use of inhaler

          -  Upper respiratory infection during past 30 days

          -  Medication that affects central nervous system function

          -  Steroid use

          -  Current pregnancy or lactation within past six months

          -  Current birth control medication or hormone replacement therapy

          -  Condition that in the judgment of the Principal Investigator is incompatible with the
             research study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William B. Ershler, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>NIA, Clinical research Unit</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Harbor Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21225</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Meles E, Giannattasio C, Failla M, Gentile G, Capra A, Mancia G. Nonpharmacologic treatment of hypertension by respiratory exercise in the home setting. Am J Hypertens. 2004 Apr;17(4):370-4.</citation>
    <PMID>15062893</PMID>
  </reference>
  <reference>
    <citation>Elliot WJ, Izzo JL Jr, White WB, Rosing DR, Snyder CS, Alter A, Gavish B, Black HR. Graded blood pressure reduction in hypertensive outpatients associated with use of a device to assist with slow breathing. J Clin Hypertens (Greenwich). 2004 Oct;6(10):553-9; quiz 560-1.</citation>
    <PMID>15470284</PMID>
  </reference>
  <reference>
    <citation>Grossman E, Grossman A, Schein MH, Zimlichman R, Gavish B. Breathing-control lowers blood pressure. J Hum Hypertens. 2001 Apr;15(4):263-9.</citation>
    <PMID>11319675</PMID>
  </reference>
  <reference>
    <citation>Benson H. The Relaxation Response. New York: Avon Books, 1975</citation>
  </reference>
  <results_reference>
    <citation>Anderson DE, McNeely JD, Chesney MA, Windham BG. Breathing variability at rest is positively associated with 24-h blood pressure level. Am J Hypertens. 2008 Dec;21(12):1324-9. doi: 10.1038/ajh.2008.292. Epub 2008 Sep 25.</citation>
    <PMID>18820654</PMID>
  </results_reference>
  <verification_date>August 2012</verification_date>
  <lastchanged_date>August 2, 2012</lastchanged_date>
  <firstreceived_date>May 18, 2006</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hypertension</keyword>
  <keyword>high blood pressure</keyword>
  <keyword>meditation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
